Skip to main content
. 2022 Jan 29;14(3):705. doi: 10.3390/cancers14030705

Figure 2.

Figure 2

Relapse-free survival (RFS) for 49 rectal cancer patients with locally advanced or recurrent rectal adenocarcinoma.